Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir

Catherine L. Cherry, Jennifer F. Hoy, Phillip Altman, James S. Rowe, Henry Krum, John Mills, Sharon R. Lewin

    Research output: Contribution to journal › Article › peer-review

    1 Citation (Scopus)

    Fingerprint

    Dive into the research topics of 'Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science